These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
332 related items for PubMed ID: 25005187
1. Therapeutic targeting of epigenetic components in amyotrophic lateral sclerosis (ALS). Lee J, Ryu H, Keum G, Yoon YJ, Kowall NW, Ryu H. Curr Med Chem; 2014; 21(31):3576-82. PubMed ID: 25005187 [Abstract] [Full Text] [Related]
2. Epigenetic Mechanisms of Gene Regulation in Amyotrophic Lateral Sclerosis. Jimenez-Pacheco A, Franco JM, Lopez S, Gomez-Zumaquero JM, Magdalena Leal-Lasarte M, Caballero-Hernandez DE, Cejudo-Guillén M, Pozo D. Adv Exp Med Biol; 2017; 978():255-275. PubMed ID: 28523551 [Abstract] [Full Text] [Related]
3. Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression. Bruneteau G, Simonet T, Bauché S, Mandjee N, Malfatti E, Girard E, Tanguy ML, Behin A, Khiami F, Sariali E, Hell-Remy C, Salachas F, Pradat PF, Fournier E, Lacomblez L, Koenig J, Romero NB, Fontaine B, Meininger V, Schaeffer L, Hantaï D. Brain; 2013 Aug; 136(Pt 8):2359-68. PubMed ID: 23824486 [Abstract] [Full Text] [Related]
4. Histone deacetylase 6 delays motor neuron degeneration by ameliorating the autophagic flux defect in a transgenic mouse model of amyotrophic lateral sclerosis. Chen S, Zhang XJ, Li LX, Wang Y, Zhong RJ, Le W. Neurosci Bull; 2015 Aug; 31(4):459-68. PubMed ID: 26164555 [Abstract] [Full Text] [Related]
5. Effects of Class II-Selective Histone Deacetylase Inhibitor on Neuromuscular Function and Disease Progression in SOD1-ALS Mice. Buonvicino D, Felici R, Ranieri G, Caramelli R, Lapucci A, Cavone L, Muzzi M, Di Pietro L, Bernardini C, Zwergel C, Valente S, Mai A, Chiarugi A. Neuroscience; 2018 May 21; 379():228-238. PubMed ID: 29588251 [Abstract] [Full Text] [Related]
6. Enhancing NAD+ Salvage Pathway Reverts the Toxicity of Primary Astrocytes Expressing Amyotrophic Lateral Sclerosis-linked Mutant Superoxide Dismutase 1 (SOD1). Harlan BA, Pehar M, Sharma DR, Beeson G, Beeson CC, Vargas MR. J Biol Chem; 2016 May 13; 291(20):10836-46. PubMed ID: 27002158 [Abstract] [Full Text] [Related]
7. Astrogliosis in amyotrophic lateral sclerosis: role and therapeutic potential of astrocytes. Vargas MR, Johnson JA. Neurotherapeutics; 2010 Oct 13; 7(4):471-81. PubMed ID: 20880509 [Abstract] [Full Text] [Related]
10. Early pathogenesis in the adult-onset neurodegenerative disease amyotrophic lateral sclerosis. van Zundert B, Izaurieta P, Fritz E, Alvarez FJ. J Cell Biochem; 2012 Nov 13; 113(11):3301-12. PubMed ID: 22740507 [Abstract] [Full Text] [Related]
12. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex. Thomsen GM, Gowing G, Latter J, Chen M, Vit JP, Staggenborg K, Avalos P, Alkaslasi M, Ferraiuolo L, Likhite S, Kaspar BK, Svendsen CN. J Neurosci; 2014 Nov 19; 34(47):15587-600. PubMed ID: 25411487 [Abstract] [Full Text] [Related]
15. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Milanese M, Giribaldi F, Melone M, Bonifacino T, Musante I, Carminati E, Rossi PI, Vergani L, Voci A, Conti F, Puliti A, Bonanno G. Neurobiol Dis; 2014 Apr 19; 64():48-59. PubMed ID: 24361555 [Abstract] [Full Text] [Related]
18. Epigenetics in amyotrophic lateral sclerosis: a role for histone post-translational modifications in neurodegenerative disease. Bennett SA, Tanaz R, Cobos SN, Torrente MP. Transl Res; 2019 Feb 19; 204():19-30. PubMed ID: 30391475 [Abstract] [Full Text] [Related]
19. ALS: a disease of motor neurons and their nonneuronal neighbors. Boillée S, Vande Velde C, Cleveland DW. Neuron; 2006 Oct 05; 52(1):39-59. PubMed ID: 17015226 [Abstract] [Full Text] [Related]